Danielle Antalffy

Stock Analyst at UBS

(3.58)
# 856
Out of 5,040 analysts
182
Total ratings
50%
Success rate
6.14%
Average return

Stocks Rated by Danielle Antalffy

Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $135$140
Current: $102.39
Upside: +36.73%
Johnson & Johnson
Oct 14, 2025
Maintains: Buy
Price Target: $190$214
Current: $192.47
Upside: +11.19%
Inspire Medical Systems
Sep 22, 2025
Downgrades: Neutral
Price Target: $230$89
Current: $80.17
Upside: +11.01%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94$95
Current: $94.21
Upside: +0.84%
Treace Medical Concepts
Aug 8, 2025
Maintains: Neutral
Price Target: $8.6$6.5
Current: $6.79
Upside: -4.27%
RxSight
Aug 8, 2025
Maintains: Neutral
Price Target: $16$8
Current: $8.43
Upside: -5.10%
Enovis
Aug 8, 2025
Maintains: Buy
Price Target: $65$57
Current: $32.52
Upside: +75.30%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Sell
Price Target: $91$96
Current: $103.16
Upside: -6.94%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Neutral
Price Target: $20$17
Current: $14.66
Upside: +15.96%
Baxter International
Aug 4, 2025
Maintains: Neutral
Price Target: $35$24
Current: $22.99
Upside: +4.39%
Maintains: Buy
Price Target: $125$134
Current: $75.23
Upside: +78.12%
Maintains: Buy
Price Target: $105$106
Current: $71.06
Upside: +49.17%
Maintains: Neutral
Price Target: $547$585
Current: $551.30
Upside: +6.11%
Maintains: Buy
Price Target: $60$58
Current: $37.39
Upside: +55.12%
Maintains: Neutral
Price Target: $19$16
Current: $15.48
Upside: +4.97%
Maintains: Buy
Price Target: $5.5$5
Current: $5.20
Upside: -3.85%
Maintains: Buy
Price Target: $146$148
Current: $126.34
Upside: +17.14%
Maintains: Neutral
Price Target: $366$370
Current: $383.06
Upside: -3.41%
Maintains: Neutral
Price Target: $90$75
Current: $76.53
Upside: -2.00%
Initiates: Neutral
Price Target: $2.25
Current: $2.22
Upside: +1.35%
Maintains: Outperform
Price Target: $300$280
Current: $323.46
Upside: -13.44%
Maintains: Outperform
Price Target: $975$825
Current: $15.20
Upside: +5,327.63%
Maintains: Outperform
Price Target: $12$14
Current: $18.05
Upside: -22.44%
Maintains: Outperform
Price Target: $75$100
Current: $56.52
Upside: +76.94%
Maintains: Outperform
Price Target: $15$12
Current: $10.54
Upside: +13.85%
Maintains: Outperform
Price Target: $25$30
Current: $34.62
Upside: -13.34%
Maintains: Outperform
Price Target: $40$45
Current: $35.97
Upside: +25.10%
Maintains: Market Perform
Price Target: $270$275
Current: $186.53
Upside: +47.43%
Maintains: Outperform
Price Target: $26$20
Current: $4.11
Upside: +386.62%
Maintains: Market Perform
Price Target: $72$42
Current: $8.97
Upside: +368.23%
Downgrades: Market Perform
Price Target: $60
Current: $7.35
Upside: +716.33%
Initiates: Outperform
Price Target: $15
Current: $0.84
Upside: +1,681.47%